financetom
Business
financetom
/
Business
/
Globus Medical Insider Sold Shares Worth $11,050,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Globus Medical Insider Sold Shares Worth $11,050,000, According to a Recent SEC Filing
Nov 25, 2024 2:09 PM

04:32 PM EST, 11/25/2024 (MT Newswires) -- Daniel T Scavilla, Director, President, CEO, on November 21, 2024, sold 130,000 shares in Globus Medical ( GMED ) for $11,050,000.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1237831/000095017024130588/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Terex Shares Fall After Q3 Revenue Miss
Update: Terex Shares Fall After Q3 Revenue Miss
Oct 30, 2025
01:26 PM EDT, 10/30/2025 (MT Newswires) -- (Updates with recent stock price movement in the headline and first paragraph.) Terex ( TEX ) shares were down roughly 17% in recent Thursday trading after Q3 revenue missed analysts' estimates. The company earlier posted Q3 adjusted earnings of $1.50 per diluted share, up from $1.46 a year earlier. Analysts polled by FactSet...
EU tech chief Virkkunen to meet chipmaker Nexperia amid supply worries
EU tech chief Virkkunen to meet chipmaker Nexperia amid supply worries
Oct 30, 2025
BRUSSELS, Oct 30 (Reuters) - EU tech chief Henna Virkkunen will meet chipmaker Nexperia on Friday, she said on X, amid concerns about a deepening supply squeeze linked to the Dutch company. Tomorrow meeting @Nexperia. Important lessons being drawn for our #ChipsAct 2.0 foreseen beginning of 2026, Virkkunen said on X. She had hosted virtual meetings with the CEOs of...
--Metsera Had Talks With Bristol-Myers Prior to Pfizer, Novo Nordisk Bids, The Wall Street Journal Reports
--Metsera Had Talks With Bristol-Myers Prior to Pfizer, Novo Nordisk Bids, The Wall Street Journal Reports
Oct 30, 2025
01:20 PM EDT, 10/30/2025 (MT Newswires) -- Price: 44.65, Change: +2.05, Percent Change: +4.80 ...
Market Chatter: Metsera Had Talks With Bristol-Myers Prior to Pfizer, Novo Nordisk Bids
Market Chatter: Metsera Had Talks With Bristol-Myers Prior to Pfizer, Novo Nordisk Bids
Oct 30, 2025
01:25 PM EDT, 10/30/2025 (MT Newswires) -- Metsera (MTSR) entered into exclusive talks with Bristol-Myers Squibb ( BMY ) prior to the deal it reached with Pfizer ( PFE ) in September and Thursday's bid by Novo Nordisk ( NVO ), The Wall Street Journal reported Thursday, citing people familiar with the matter. Metsera and Bristol-Myers Squibb ( BMY )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved